Upregulation of PLOD2 has been observed in various human malignancies, including breast cancer [5], biliary cancer [6], colorectal cancer [7], glioma [8], and liver cancer [9], as well as in CESC [10, 11]. This evidence concerns the gene PLOD2 and cervical squamous cell carcinoma.